大骨瓣开颅术联合吡拉西坦对重度颅脑损伤患者神经功能重建及血清标志物的影响OA
Effects of Large Bone Flap Craniotomy Combined with Piracetam on Neurological Function Reconstruction and Serum Markers in Patients with Severe Traumatic Brain Injury
目的 探讨吡拉西坦结合大骨瓣开颅手术治疗对重度颅脑损伤患者血清S100B蛋白(S100B)、神经元特异性烯醇化酶(neuron-specific enolase,NSE)水平的影响.方法 选取2020年1月至2024年12月宿迁市泗洪县泗洪医院收治的88例重度颅脑损伤患者为研究对象,采用随机数字表法分为对照组(n=44)和观察组(n=44).对照组采用大骨瓣开颅手术,观察组在对照组基础上联合吡拉西坦治疗.比较两组患者的血清S100B、NSE水平、神经功能(NIHSS评分)、意识状态(GCS评分)、生活质量(GQOL-74评分)及临床疗效.结果 治疗前,两组患者在血清S100B、NSE水平以及NIHSS、GCS、GQOL-74评分方面均无明显差异(P>0.05).完成治疗后,两组患者的血清S100B、NSE水平和NIHSS评分均较治疗前有所降低,其中观察组的降幅更为显著(P<0.001);同时,两组的GCS评分与GQOL-74评分较治疗前均有所提升,且观察组的升幅明显高于对照组(P<0.001).在临床疗效方面,观察组的总有效率达到95.45%(42/44),显著高于对照组的79.55%(35/44),差异具有统计学意义(P=0.024).结论 吡拉西坦结合大骨瓣开颅手术能有效降低重度颅脑损伤患者血清S100B、NSE水平,促进神经功能恢复,改善意识状态,提高患者生活质量,临床疗效显著.
Objective To investigate the effects of piracetam combined with large bone flap craniotomy on the levels of serum S100B protein(S100B)and neuron-specific enolase(NSE)in patients with severe traumatic brain inju-ry.Methods A total of 88 patients with severe traumatic brain injury admitted to Sihong Hospital,Sihong County,Suqian City from January 2020 to December 2024 were selected as the study subjects.They were randomly divided into a control group(n=44)and an observation group(n=44)using a random number table method.The control group underwent large bone flap craniotomy,while the observation group received piracetam treatment in addition to the surgery.The serum S100B and NSE levels,neurological function(NIHSS score),state of consciousness(GCS score),quality of life(GQOL-74 score),and clinical efficacy were compared between the two groups.Results Before treatment,there were no statis-tically significant differences between the two groups in terms of serum S100B and NSE levels,as well as NIHSS,GCS,and GQOL-74 scores(P>0.05).After the completion of treatment,the serum levels of S100B and NSE,along with NIHSS scores,decreased in both groups compared to before treatment,with the observation group showing a significantly greater reduction(P<0.001).Meanwhile,GCS scores and GQOL-74 scores in both groups increased compared to pre-treatment levels,and the improvements were significantly more pronounced in the observation group than in the control group(P<0.001).Regarding clinical efficacy,the total effective rate in the observation group was 95.45%(42/44),which was significantly higher than 79.55%(35/44)in the control group,and the difference was statistically significant(P=0.024).Conclusion Piracetam combined with large bone flap craniotomy can effectively reduce the serum S100B and NSE levels in patients with severe traumatic brain injury,promote the recovery of neurological function,improve the state of consciousness,enhance the quality of life of patients,and achieve significant clinical efficacy.
周华海;刘瑞;卢玮;罗正祥
宿迁市泗洪县泗洪医院神经外科,江苏 宿迁 223900宿迁市泗洪县泗洪医院神经外科,江苏 宿迁 223900宿迁市泗洪县泗洪医院神经外科,江苏 宿迁 223900南京脑科医院神经外科,南京 210000
吡拉西坦大骨瓣开颅手术重度颅脑损伤
piracetamlarge bone flap craniotomysevere traumatic brain injury
《中华灾害救援医学》 2026 (2)
173-176,4
评论